These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 9082442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
    D'Alonzo GE, Smolensky MH, Feldman S, Gianotti LA, Emerson MB, Staudinger HW, Sauter R, Steinijans VW.
    Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
    Boner AL, Sette L, Vallone G, Plebani M, Messori A.
    Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
    [Abstract] [Full Text] [Related]

  • 6. [Inhibition of growth hormone secretion by theophylline in asthmatic children].
    Baum WF, Klöditz E, Schneyer U.
    Pneumologie; 1996 Mar; 50(3):238-41. PubMed ID: 8919920
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups].
    Berdel D, von Berg A, Reinhardt D, Heimann G, Steinijans VW, Sauter R.
    Pneumologie; 1991 Nov; 45 Suppl 4():863-6. PubMed ID: 1812481
    [Abstract] [Full Text] [Related]

  • 8. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
    Oosterhuis B, Brannan MD, Groen H, Peeters PA, Hempenius J, Radwanski E, Nomeir AA, Affrime MB, Jonkman JH.
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
    [Abstract] [Full Text] [Related]

  • 9. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
    Sallent J, Hill M, Stecenko A, McKenzie M, Hendeles L.
    Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
    [Abstract] [Full Text] [Related]

  • 10. [Value of a daily dose of theophylline in the treatment of nocturnal asthma].
    Godard P, Kleisbauer JP, Muir JF, Paramelle B, Mazoyer F.
    Rev Pneumol Clin; 1986 Jan; 42(5):262-5. PubMed ID: 3809874
    [Abstract] [Full Text] [Related]

  • 11. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M, Fukutomi O, Kondo N, Kato Z, Nakashima Y, Shinoda S, Agata H, Kondo T, Imaeda N, Orii T.
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [Abstract] [Full Text] [Related]

  • 12. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
    Ferrari M, Olivieri M, Lampronti G, Bonazza L, Biasin C, Nacci P, Talamini G, Lo Cascio V.
    Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA, Kisicki J, Straughn AB.
    Clin Ther; 1994 Nov; 16(4):686-92. PubMed ID: 7982257
    [Abstract] [Full Text] [Related]

  • 14. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
    Götz J, Sauter R, Steinijans VW, Jonkman JH.
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
    [Abstract] [Full Text] [Related]

  • 15. Apparent decrease in population clearance of theophylline: implications for dosage.
    Asmus MJ, Weinberger MM, Milavetz G, Marshik P, Teresi ME, Hendeles L.
    Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
    [Abstract] [Full Text] [Related]

  • 16. [Continuous treatment of asthma in children with theophylline retard].
    de Blic J, Scheinmann P, Benoist MR, Ruff F, Paupe J.
    Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
    Ukena D, Koper I, Braun H, Leutz M, Schlimmer P, Sybrecht GW.
    Pneumologie; 1997 Mar; 51(3):317-23. PubMed ID: 9173422
    [Abstract] [Full Text] [Related]

  • 18. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A, Aviram M, Gorodischer R.
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [Abstract] [Full Text] [Related]

  • 19. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS, Guleria R, Misra A, Pande JN.
    Indian J Chest Dis Allied Sci; 1997 Aug; 39(3):143-7. PubMed ID: 9357147
    [Abstract] [Full Text] [Related]

  • 20. [Clinical use of theophylline retard Oranienburg].
    Slapke J, Hummel S, Wilke A, Wenz W, Meister W, Förster R, Wiesner B, Rentsch E, Nussbücker B.
    Z Erkr Atmungsorgane; 1988 Aug; 170(1):49-53. PubMed ID: 3291417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.